Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

85.96EUR
11:35am EDT
Price Change (% chg)

€-0.53 (-0.61%)
Prev Close
€86.49
Open
€86.52
Day's High
€86.52
Day's Low
€85.49
Volume
2,879
Avg. Vol
5,200
52-wk High
€147.40
52-wk Low
€69.00

ALCAR.PA

Chart for ALCAR.PA

About

Carmat SAS is a France-based Company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The Company formed a network of partnerships with hospitals and various scientific... (more)

Overall

Beta: 1.74
Market Cap (Mil.): €370.48
Shares Outstanding (Mil.): 4.28
Dividend: --
Yield (%): --

Financials

  ALCAR.PA Industry Sector
P/E (TTM): -- 30.89 36.40
EPS (TTM): -3.39 -- --
ROI: -97.88 9.63 18.27
ROE: -170.59 11.33 19.15
Search Stocks

BRIEF-Carmat shares rise 19 pct, to resume artificial heart tests

PARIS, July 17 - Carmat SA : * Shares in Carmat SA rise 19.4 percent after company says to resume

17 Jul 2014

BRIEF-Carmat shares fall 9.7 pct

PARIS, March 17 - Carmat SA : * Shares fall 9.7 percent after says to continue clinical trial once has

17 Mar 2014

Heart maker Carmat to wait before next transplant: founder

PARIS - French artificial heart maker Carmat will not carry out any more human transplants until it has determined the cause of the death of the first patient fitted with its device, one of the company's co-founders said on Sunday.

16 Mar 2014

Heart maker Carmat to wait before next transplant-founder

* Founder says will take "few weeks" to find reasons for death

16 Mar 2014

UPDATE 2-Carmat continues trials of artificial heart after patient death

* Carmat shares, suspended Tuesday, hit 2-year low (Adds share price reaction, analyst comments, context)

05 Mar 2014

BRIEF-Carmat falls 10 pct after death of first artificial heart patient

PARIS, March 5 - Carmat SA : * Shares fall 10 percent after death of first artificial heart patient

05 Mar 2014

UPDATE 1-Carmat to continue human trials of artificial heart

PARIS, March 4 - French company Carmat said on Tuesday that it would proceed with further clinical trials in humans of its artificial heart after the death of the first patient fitted with the device.

04 Mar 2014

Carmat says to continue human trials of artificial heart

PARIS, March 4 - French company Carmat said on Tuesday that it would proceed with further clinical trials in humans of its artificial heart after the death of the first patient fitted with the device.

04 Mar 2014

BRIEF-Carmat shares suspended pending company statement -Euronext

PARIS, March 4 - Carmat SA : * Shares suspended at the market opening pending a company statement - Euronext * The first patient fitted with Carmat's artificial heart died on Sunday, the hospital that had performed the transplant said.

04 Mar 2014

First patient fitted with Carmat artificial heart dies

PARIS - The first patient fitted with an artificial heart made by the French company Carmat has died, the hospital that had performed the transplant in December said on Monday.

03 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Edison Investment Research
$10.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks